U.S. Markets closed

Syneos Health, Inc. (SYNH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
54.20-0.54 (-0.99%)
At close: 4:00PM EDT

54.20 0.00 (0.00%)
After hours: 4:47PM EDT

Syneos Health, Inc.

1030 Sync Street
Morrisville, NC 27560
United States
919 876 9300

IndustryDiagnostics & Research
Full Time Employees24,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Alistair MacdonaldCEO & Director1.76M652.82k1970
Mr. Jason M. MeggsChief Financial Officer760.92kN/A1976
Mr. Jonathan OlefsonGen. Counsel & Corp. Sec.823.57kN/A1976
Ms. Michelle KeefePres of Commercial Solutions798.49kN/A1967
Mr. Paul D. ColvinPres of Clinical Solutions794.52kN/A1970
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Corporate Governance

Syneos Health, Inc.’s ISS Governance QualityScore as of December 9, 2019 is 4. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 6; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.